Advertisement

Topics

Adjuvant Pembrolizumab Beneficial in Stage III Melanoma

08:00 EDT 16 Apr 2018 | Drugs.com

MONDAY, April 16, 2018 -- Pembrolizumab is associated with significantly longer recurrence-free survival than placebo as adjuvant therapy for high-risk stage III melanoma, according to a study published online April 15 in the New England Journal of...

Original Article: Adjuvant Pembrolizumab Beneficial in Stage III Melanoma

NEXT ARTICLE

More From BioPortfolio on "Adjuvant Pembrolizumab Beneficial in Stage III Melanoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...